Literature DB >> 7438476

The effect of oxprenolol, acebutolol and propranolol on thyroid hormones in hyperthyroid subjects.

M K Jones, R John, G R Jones.   

Abstract

Serum thyroid hormone levels were measured before and during 10 days treatment with acebutolol (400 mg/day), oxprenolol (160 mg/day) and propranolol (160 mg/day) eighteen hyperthyroid patients. A significant change in thyroid hormone concentrations was seen only in the group treated with propranolol. Propranolol should be used in preference to beta-adrenoreceptor blocking drugs with partial agonist activity, in the treatment of hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7438476     DOI: 10.1111/j.1365-2265.1980.tb03394.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

Review 1.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

2.  Nadolol in thyrotoxicosis.

Authors:  N R Peden; T E Isles; I H Stevenson; J Crooks
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

3.  Beta-adrenoreceptor blocking drugs and thyroid hormones in hyperthyroid subjects.

Authors:  M K Jones; J Birtwell; D R Owens; G R Jones; M Lewis
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

Review 4.  The effects of drugs on tests of thyroid function.

Authors:  P H Davies; J A Franklyn
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 5.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

6.  Acute effect of atenolol on serum thyroid hormones in hyperthyroid patients.

Authors:  S Rassu; A Masala; S Alagna; P P Rovasio; M Langer
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

7.  Pharmacokinetics of propranolol and sotalol in hyperthyroidism.

Authors:  A Aro; M Anttila; T Korhonen; H Sundquist
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 8.  Cardioselective beta-blockers for chronic obstructive pulmonary disease.

Authors:  S Salpeter; T Ormiston; E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.